Inventor · disambiguated record
Xavier Barril Alonso
Also filed as: BARRIL-ALONSO XAVIER
4 granted patents·5 pending applications·0 citations·filing 2012–2022
53Inventor score
Files withMINORYX THERAPEUTICS S L4GAIN THERAPEUTICS SA2FUNDACIO PRIVADA INST DINVESTIGACIO ONCOLOGICA DE VALL HEBRON1UNIV BARCELONA1YEDA RES & DEV1
Top patents by PatentIndex Score
9 records- 0156US11739072B2Heteroaryl compounds and their useMINORYX THERAPEUTICS S L·Filed 2021·Granted Aug 29, 2023·0 cites·30 claims
- 0246US12286439B2Inhibitors of ERK nuclear translocationYEDA RES & DEV·Filed 2021·Granted Apr 29, 2025·0 cites·8 claims
- 0346US2023140216A1Combination therapy for treating mps1GAIN THERAPEUTICS SA·Filed 2021·Application pending·0 cites
- 0444US2023058312A1Aryl and heteroaryl compounds, and therapeutic uses thereof in conditions associated with the alteration of the activity of galactocerebrosidaseGAIN THERAPEUTICS SA·Filed 2020·Application pending·0 cites
- 0543US2024208998A1Compounds for use in the treatment of hyperproliferative disordersFUNDACIO PRIVADA INST DINVESTIGACIO ONCOLOGICA DE VALL HEBRON·Filed 2022·Application pending·0 cites
- 0641US11174242B2Heteroaryl compounds and their useMINORYX THERAPEUTICS S L·Filed 2017·Granted Nov 16, 2021·0 cites·28 claims
- 0738US2016168132A1Di(hetero)arylamides and sulfonamides, methods for their preparation and therapeutic uses thereofMINORYX THERAPEUTICS S L·Filed 2014·Application pending·0 cites
- 0836US11440898B2Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidaseMINORYX THERAPEUTICS S L·Filed 2017·Granted Sep 13, 2022·0 cites·23 claims
- 0932US2014358450A1Method of Binding Site and Binding Energy Determination by Mixed Explicit Solvent SimulationsUNIV BARCELONA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xavier Barril Alonso files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →